logo
logo
Sign in

Primary Sclerosing Cholangitis: A Rare but Serious Liver Disease

avatar
ashwini bakhade
Primary Sclerosing Cholangitis: A Rare but Serious Liver Disease

What is Primary Sclerosing Cholangitis?


Primary sclerosing cholangitis (PSC) is a chronic disease characterized by inflammation and scarring of the bile ducts within the liver. The bile ducts are tubes that carry bile from the liver to the small intestine. When they become inflamed and scarred, bile cannot flow properly and damage to the liver may occur over time.


Causes and Risk Factors of Primary Sclerosing Cholangitis


The exact cause of PSC is unknown, but it is considered an autoimmune disease where the immune system mistakenly attacks the body's own cells and tissues. Genetics also plays a role, as individuals with certain genes may have a higher risk of developing PSC. Some other potential risk factors include:


- Inflammatory Bowel Disease (IBD): Around 75-80% of individuals with PSC also have IBD, most commonly ulcerative colitis. Having IBD significantly increases the risk of PSC.


- Family History: First-degree relatives of those with PSC are 6-8 times more likely to develop the disease. Identical twins have a 30-40% concordance rate.


- Gender: PSC predominantly affects males. The male to female ratio is approximately 2-3:1.


- Smoking: Smoking may have a protective effect against developing Primary Sclerosing Cholangitis, though it is not recommended due to health risks.


Symptoms of Primary Sclerosing Cholangitis


PSC often does not cause any symptoms in its early stages. As the disease progresses, common symptoms can include:


- Itchiness (pruritus)


- Fatigue


- Abdominal pain in the right upper abdomen


- Clay or pale stools


- Dark urine


- Loss of appetite and unintended weight loss


- Jaundice (yellowing of the skin and eyes)


Some people may experience no symptoms at all until advanced stages of liver disease are reached. Symptoms tend to come and go over time.


Diagnosis of Primary Sclerosing Cholangitis


- Liver Function Tests: Blood tests are done to check levels of bilirubin and liver enzymes, which may be elevated.


- Imaging Tests: Ultrasound, MRCP, or ERCP are commonly performed to view the bile ducts directly and check for strictures or dilations.


- Liver Biopsy: A small sample of liver tissue is examined under a microscope to look for characteristic features of PSC.


- Colonoscopy: Done to examine the colon and rule out other conditions like PBC overlapping with IBD.


The combination of characteristic test results and bile duct abnormalities on imaging can confirm a diagnosis of PSC. A definitive diagnosis requires ruling out other potential causes as well.


Complications of Primary Sclerosing Cholangitis


Without treatment, PSC can become advanced and lead to serious complications such as:


- Liver Cirrhosis: Long-term scarring can progress to cirrhosis in around 50% of patients within 10-20 years of diagnosis.


- Liver Failure: Cirrhosis can eventually cause complete liver failure requiring a transplant as the only life-saving option.


- Cholangiocarcinoma: A rare form of liver cancer that occurs in 5-10% of individuals within 10-20 years after diagnosis.


- Colorectal Cancer: Patients with coexistent IBD have a higher risk due to chronic inflammation in the colon. Regular surveillance is important.


- Portal Hypertension: Elevated blood pressure in the portal vein, with risk of variceal bleeding or ascites fluid buildup.


- Other Complications: Jaundice, itching, infections, malnutrition, osteoporosis, and worsening of symptoms from progressive disease.


Treatment and Management of Primary Sclerosing Cholangitis


There is no cure for PSC, so treatment aims to slow disease progression and prevent complications. Medications, procedures, or surgery may be used as needed:


- Ursodeoxycholic Acid: A bile acid medication that helps bile flow; benefits are seen in some but not all.


- Endoscopic or Surgical Interventions: Stents, balloon dilation, or surgery to relief bile duct strictures causing blockages.


- Antibiotics: Used prophylactically or to treat infections like sclerosing cholangitis.


- Monitoring: Regular medical appointments and testing to watch for complications and consider liver transplant evaluation.


- Supportive Care: Managing itching, fatigue, nutritional support, and treating any progression of IBD or other conditions.


- Liver Transplant: The only life-saving option once end-stage liver disease or failure develops.


Prognosis and Outlook


Without treatment, 50% of people with PSC will develop cirrhosis within 10-20 years of diagnosis. The 10-year and 20-year survival after diagnosis is around 80-90% and 60-70%, respectively. With close monitoring and prompt treatment of complications, the outlook can be improved. But PSC remains a complex, chronic condition without a cure. Continued research is ongoing to better understand this disease and develop more effective therapies.

 

Get more insights on This Topic- Primary Sclerosing Cholangitis

 

collect
0
avatar
ashwini bakhade
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more